You are here

AbbVie

Can cancer charity efforts from Roche, Bristol, AbbVie and more boost pharma's reputation?

Fierce Pharma

Mon, 10/23/17 - 09:44 am

Bristol-Myers Squibb

What's next for biopharma Q3 earnings

Biopharma Dive

Sat, 10/21/17 - 09:50 pm

Bristol-Myers Squibb

Gilead Sciences

Pfizer's Lyrica takes pharma TV spending crown from AbbVie's Humira for September

Fierce Pharma

Mon, 10/9/17 - 11:24 am

AbbVie hit with $140M verdict in second bellwether AndroGel case

Fierce Pharma

Fri, 10/6/17 - 11:39 am

3 Big Pharma Stocks Set to Succeed

Motley Fool

Thu, 10/5/17 - 09:36 am

The new Biotech Scorecard: 10 make-or-break industry events for the fourth quarter

Stat

Tue, 10/3/17 - 11:50 am

Axovant Sciences

SAGE Therapeutics

Global Blood Therapeutics

DBV Technologies

Amicus Therapeutics

Spark Therapeutics

Revance Therapeutics

Abbvie, Amgen Deal on Humira Biosimilars Likely to Cost CMS More Than $1B

RAPS.org

Mon, 10/2/17 - 11:18 am

AbbVie: Better Late Than Never

Barron's

Mon, 10/2/17 - 10:40 am

Merck Hepatitis C exit could lift the space’s two remaining drugmakers

Marketwatch

Sun, 10/1/17 - 10:04 am

Gilead Sciences

How Good Is AbbVie's Humira Deal With Amgen?

Motley Fool

Fri, 09/29/17 - 10:06 am

Pharma's pricing pledges? Maybe they weren't such a good idea in the first place, experts say

Fierce Pharma

Thu, 09/28/17 - 09:55 am

Under Amgen and AbbVie agreement, rival drug to AbbVie's Humira expected to launch in 2023

Marketwatch

Thu, 09/28/17 - 09:50 am

What pledge? AbbVie executives may back off their vow to limit price hikes: report

Fierce Pharma

Mon, 09/25/17 - 07:34 pm

AbbVie's Unfazed by the Risk of Generic Humira

Motley Fool

Mon, 09/25/17 - 09:45 am

AbbVie pairs up another ADC cancer drug with Bristol-Myers Squibb's Opdivo

Fierce Biotech

Sat, 09/23/17 - 10:02 am

Bristol-Myers Squibb

antibody-drug conjugate

non-small cell lung cancer

AbbVie’s top execs paint a rosy pic of the mega-blockbuster future looming for Humira and PhIII drugs

Endpoints

Fri, 09/22/17 - 09:19 am

AbbVie, Roche to seek broader market for leukemia drug after trial success

BioPharma Dive

Tue, 09/19/17 - 10:23 pm

clinical trials

chronic lymphocytic leukemia

Which of These 5 Will Be the Best-Selling Drug Worldwide in 2020?

Motley Fool

Sat, 09/16/17 - 12:01 pm

Bristol-Myers Squibb

AbbVie keen on JAK inhibitor despite safety concerns

BioPharma Dive

Tue, 09/12/17 - 04:22 pm

rheumatoid arthritis

AbbVie and Pfizer hover at top, J&J Stelara surges in August TV pharma ad spend

Fierce Pharma

Mon, 09/11/17 - 09:06 pm

Pages